Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
02/2009
02/12/2009US20090042882 Substituted acetamides as modulators of the ep2 receptor
02/12/2009US20090042875 Substituted heterocyclic compounds and uses thereof
02/12/2009US20090042866 Tetrahydrocarbazoles as Active Agents for Inhibiting VEGF Production by Translational Control
02/12/2009US20090042862 Novel compounds
02/12/2009US20090042854 Hexahydro-3H-Pyrrolizin-3-Ones Useful as Tachykinin Receptor Antagonists
02/12/2009US20090042114 Halogenated oxime derivatives and the use therof as latent acids
02/12/2009US20090041722 Indole indane amide compounds useful as cb2 agonists and method
02/12/2009US20090041670 Near Infrared Fluorescent Contrast Agent And Method For Fluorescence Imaging
02/12/2009US20090039765 Light emitting polymer composition and polymer light emitting device
02/12/2009DE102006047231B4 Substituierte Indeno[1,2-b]indolderivate als neue Hemmstoffe der Protein Kinase CK2 und ihre Verwendung als Tumor Therapeutika, Cytostatika und Diagnostika Substituted indeno [1,2-b] indole derivatives as new inhibitors of protein kinase CK2 and their use as antitumor agents, cytostatic agents and diagnostic agents
02/12/2009CA2695852A1 Cyclic amine compounds
02/12/2009CA2695461A1 Renin inhibitors
02/12/2009CA2695357A1 Process for preparing chiral compounds
02/12/2009CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/11/2009EP2021324A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
02/11/2009CN101365679A Methods and compounds for preparing cc-1065 analogs
02/11/2009CN101365678A Modulators of the h3 receptor useful for the treatment of disorders related thereto
02/11/2009CN101365677A Compounds for the treatment of inflammatory disorders and microbial diseases
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/11/2009CN101362715A Preparation method of n-acetyl-5-methoxytryptamine
02/11/2009CN101362714A 2-heterocycle(C-C bond)-4-oxobutanoate and preparation method thereof
02/11/2009CN100460391C Chemical compounds.
02/11/2009CN100460390C Bi(N-methylphthalic imidine) ester preparation method
02/10/2009US7488844 Therapeutic agents
02/10/2009US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
02/10/2009US7488747 Pyrrole and pyrazole DAAO inhibitors
02/10/2009US7488745 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction
02/10/2009US7488744 Indole-type derivatives as inhibitors of p38 kinase
02/10/2009US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/10/2009CA2208671C Substituted imides as tnf inhibitors
02/05/2009WO2009016583A2 Indole amides as perfuming ingredients
02/05/2009WO2009016560A2 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/05/2009WO2009016414A1 Novel process
02/05/2009WO2009016253A2 Cyanomethyl substituted n-acyl tryptamines
02/05/2009WO2009016083A1 Degradation accelerator for polymers and polymer article comprising it
02/05/2009WO2009015407A1 Method of preparing naphthalocyanines
02/05/2009US20090036690 selected from indole-1-carboxylic acid methyl ester, indole- 1-carboxylic acid ethyl ester, indole-1-carboxylic acid isopropyl ester, indole-1-carboxylic acid allyl ester, 7-methyl-indole-1-carboxylic acid methyl ester and 5-methyl-indole-1-carboxylic acid methyl ester; used in cosmetics, perfume etc.
02/05/2009US20090036671 heating the tetrahydronaphthalic anhydride with a reagent mixture comprising ammonium nitrate; cost efficiency
02/05/2009US20090036501 2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha
02/05/2009US20090036441 Indole Derivatives With Antitumor Activity
02/05/2009US20090035810 Modified carbocyanine dyes and their conjugates
02/05/2009US20090035809 Modified Carbocyanine Dyes and Their Conjugates
02/05/2009CA2695008A1 Substituted indoles
02/05/2009CA2694608A1 A process for the preparation of almotriptan and a synthetic intermediate usable in said process
02/05/2009CA2693817A1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
02/05/2009CA2687907A1 Method of preparing naphthalocyanines
02/04/2009EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
02/04/2009EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines
02/04/2009EP2020402A1 Dehydroxylated fluorinating agent
02/04/2009EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
02/04/2009CN101360709A Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR)
02/04/2009CN101360708A Methods for purifying 2-aryl-3,3-bis(hydroxyaryl)phthalimidines
02/04/2009CN101360707A Thrombopoietin activity modulating compounds and methods
02/04/2009CN101357899A Method for preparing N-methyl phthalimide compound
02/04/2009CN100457754C Substituted indolepyridinium as anti-infective compounds
02/04/2009CN100457733C Vinyl monomer and polymer derived from the monomer, and light emitting device using the polymer
02/04/2009CN100457732C Method for preparing ropinirole
02/04/2009CN100457731C Benzamide modulators of metabotropic glutamate receptors
02/04/2009CN100457730C Indoles having anti-diabetic activity
02/04/2009CN100457729C 2,4-dihalogen-6-(c2-c3-alkyl)-phenyl substituted tetramic acid derivatives
02/03/2009US7485663 dissolving in a solvent, precipitating crystal form by cooling the solution to about -20C
02/03/2009US7485652 Indolyl derivatives as liver-X-receptor (LXR) modulators
02/03/2009US7485643 Bicyclic inhibitors of MEK and methods of use thereof
02/03/2009US7485625 Inhibitors of hepatitis C virus NS3/NS4a serine protease
02/03/2009US7485404 1-(Chloro-), 2-((1,3,3-(trimethyl-)-3H-indolium-2-yl)-vin-1,2-ylene-),6-((1,3,3-(trimethyl-)-2,3-dihydroindolin-2-ylidene)-ethanediylidene-cyclonex-1-ene;storage stability, highly sensitive to beams emitted by general-purpose semiconductor lasers
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
01/2009
01/29/2009WO2009015169A1 Indole indane amide compounds useful as cb2 agonists and method
01/29/2009WO2009014513A1 Novel dyes for the detection or quantification of desirable target molecules
01/29/2009WO2009014150A1 Benzimidazole derivative
01/29/2009WO2009013333A1 Alkylacetylene substituted acyltryptophanols
01/29/2009WO2009013299A2 Novel bradykinin b1 antagonists
01/29/2009WO2009013122A2 Azo dyes
01/29/2009WO2009012954A1 Novel estrogen receptor ligands
01/29/2009WO2009012656A1 Inhibitors for matrix metalloproteinases, pharmaceutical compositions containing them and their uses
01/29/2009WO2008089453A9 Inhibitors of d-amino acid oxidase
01/29/2009WO2007114848A3 Chemical compounds
01/29/2009US20090030062 N-{4-[(1S,5R/1R,5S)-3-azabicyclo[3.1.0]hex-1-yl]phenyl}-4-(1-methylethyl)benzenesulfonamide, used for treating drug abuse and dependence, schizophrenia , sexual disorders and as cognition activators
01/29/2009US20090030061 Benzoisoindole Derivatives And Their Use As EP4 Receptor Ligands
01/29/2009US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
01/29/2009US20090029979 5-htx modulators
01/29/2009US20090029858 Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids
01/29/2009US20090028904 Novel cochleate formulations
01/29/2009US20090026919 Phenanthrene derivative
01/29/2009DE102007035333A1 Neue substituierte Arylsulfonylglycine, deren Herstellung und deren Verwendung als Arzneimittel New substituted Arylsulfonylglycine, their preparation and their use as medicaments
01/29/2009DE102007034620A1 Neue B1-Antagonisten New B1 antagonists
01/29/2009CA2694251A1 Novel b1-antagonists
01/29/2009CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/29/2009CA2694216A1 Benzimidazole derivative
01/28/2009EP2019102A1 Alkylacetylene substituted Acyltryptophanols
01/28/2009EP2018367A1 Novel microbiocides
01/28/2009EP2018163A2 Imaging agents and methods
01/28/2009EP1418910B1 Methods for inhibiting or reversing tau filament formation polymerization
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356187A Oxidation process for the preparation of n-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and re
01/28/2009CN101353573A Phosphorescent compositions and organic light emitting devices containing them
01/28/2009CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof
01/28/2009CN101353313A Process to produce oxazolidinones
01/28/2009CN100455568C 6-position substituted indoline, production and use thereof as medicament
01/28/2009CN100455566C Novel derivatives of aminocyclohexane